Xiamen Innovax Biotech
Chinese biotech company focused on vaccine development
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Xiamen Innovax Biotech is a Chinese biotech company founded in 2001, focusing on vaccine R&D and production. Its products include recombinant hepatitis E vaccine and HPV vaccine, sold domestically and internationally.
Products and positioning
Recent events
Wantai Biological publishes IPO prospectus[1]
Wantai Biological published its IPO prospectus on the evening of April 2, stating that it planned to issue up to 43.6 million shares and raise 318 million yuan.
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/xiamen-innovax-biotech · Editorial policy · How profiles are compiled